3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
11
Osteoporosis
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Colonic Neoplasms
5
Obesity
3
Neoplasms
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Inflammation
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Bone Diseases, Metabolic
3
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Leukemia
2
Leiomyoma
2
Giant Cell Tumor of Bone
2
Gastrointestinal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Bone Diseases
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Acupuncture Therapy
10
Exercise
7
Cryotherapy
6
Paclitaxel
5
Glutamine
5
Surveys and Questionnaires
3
Duloxetine Hydrochloride
3
Dexamethasone
3
Bortezomib
3
Acetylcysteine
3
Thioctic Acid
2
Tablets
2
Sodium Chloride
2
Saline Solution
2
Physical Therapy Modalities
2
Low-Level Light Therapy
2
Fish Oils
2
Fatty Acids, Omega-3
2
ziconotide
1
sagopilone
1
pembrolizumab
1
nicotinamide-beta-riboside
1
nabilone
1
glutamic acid diethyl ester
1
enfortumab vedotin
1
allantoicase
1
Yoga
1
XELOX
1
Vitamin D
1
Vitamin B Complex
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Peripheral Nervous System Diseases
×
Vitamin D
×
Clear all
NCT02795572
2019-07-05
CIPN
AHS Cancer Control Alberta
Phase 2
Terminated
13 enrolled